Interacting Drugs |
Irbesartan vs Carvedilol |
Security Level |
 |
Mechanism |
Carvedilol: CYP2C9 Inhibitors (Moderate) may increase the serum concentration of Carvedilol. Specifically, concentrations of the S-carvedilol enantiomer may be increased. |
Management |
Monitor therapy |
Irbesartan vs Carvedilol
Post Review about Irbesartan vs Carvedilol Click here to cancel reply.
Other Interactions of Irbesartan
Other Interactions of Carvedilol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.